GeneSegues, Inc. Appoints New SAB Member
GeneSegues, Inc., a biopharmaceutical company that develops nanoencapsulated therapeutics, today announced the appointment of Dr. Erkki Ruoslahti, Ph.D., M.D., to its Scientific Advisory Board (SAB). Dr. Ruoslahti holds the position of Distinguished Professor at the Burnham Institute in La Jolla, California.